In the CY 2023 OPPS/ASC Final Rule, CMS established a policy to make a single blended payment for devices and services in Category B investigational device exemption (IDE) studies to preserve the scientific validity of these studies. This policy involves creating or revising HCPCS codes to ...
Payment Update for Investigational Device Exemption for Clinical Studies Medicare can pay for routine items and services provided in a U.S. Food and Drug Administration (FDA) approved Category A (Experimental) study if CMS determines that the Medicare coverage investigational device exem...
November 15, 2024: HRSAannounceda meeting of the Advisory Committee on Training in Primary Care Medicine and Dentistry. This is a virtual meeting open to the public. II. Reports, Studies, & Analyses On September 3, 2024, the HHS Office of Inspector General (OIG) published a report entitled...
Ltd. (hereafter “Shionogi”) today announces that the Centers for Medicare & Medicaid Services (CMS) has granted a new technology add-on payment (NTAP) for FETROJA®(cefiderocol) when administered in the hospital inpatient setting. FETROJA is indicated for complicated urinary tract infections...
(typically an immune-mediated inflammatory disease such as arthritis or Wegener's granulomatosis), the side effects of medicine or as a complication of ocular surgery.6-8,12-17 This makes the epide- miology difficult to calculate.6-8,12-17 In one recent study, a slight preponder- ance ...